Investigation of the roles for CaV1.2 in non-excitable tissue during development

研究 CaV1.2 在发育过程中非兴奋组织中的作用

基本信息

批准号：
9348666
负责人：
Geoffrey S Pitt
金额：
$ 45.25万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-08 至 2021-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9348666
关键词：
Action Potentials Affect Agonist Apoptosis Apoptotic Arrhythmia Autistic Disorder Automobile Driving Behavior Bone Density Bone Development Brain Cells Chondrocytes Clinical Complex Congenital Abnormality Data Development Digit structure Disease Electrophysiology (science)Embryo Endocrine Functional disorder Future Genes Grant Growth Factor Heart Hormones Hyperplasia Hypertrophy Image Internet Investigation Knock-in Knock-out Knowledge Lead Limb structure Location Mandible Membrane Potentials Methods Microscopic Molecular Mosaicism Mus Mutation Neurons Osteoporosis Patients Pattern Pharmacology Phenotype Prevention strategy Proliferating Property Proteins Regulation Rest Role Signal Pathway Signal Transduction Signaling Molecule Skin Speed Syndactyly Technology Testing Timothy syndrome Tissues bone experimental study gain of function gain of function mutation loss of function morphogens mouse model mutant novel osteogenic patch clamp public health relevance response substantia spongiosa targeted agent targeted delivery tool treatment strategy voltage

项目摘要

Although voltage-gated Ca2+ channels (VGCCs) have been studied extensively for their roles in neurons, heart, and hormone-secreting cells, the especially broad array of abnormalities in Timothy syndrome (TS) implies unexpected roles for VGCCs during development. TS is due to a gain-of-function mutation in CACNA1C, the gene encoding the pore-forming α1C subunit of the L-type Ca2+ channel CaV1.2. Intense focus on TS has centered on how the mutant channels lead to cardiac arrhythmias or autism, but almost no studies have examined CaV1.2 contributions to accompanying phenotypes such as syndactyly. Unraveling these CaV1.2 contributions will be fruitful, since these TS phenotypes include multiple common birth defects, implying that dysfunctional CaV1.2 signaling generally is a frequent cause of developmental abnormalities. Moreover, the consequences of dysfunctional CaV1.2 in birth defects demonstrates that CaV1.2 has important, but understudied roles in normal development. Here we propose three Aims: 1: Test the hypothesis that Ca2+ influx through TS mutant CaV1.2 affects interdigital apoptosis; 2: Test the hypothesis that Ca2+ influx through CaV1.2 controls bone development; and 3: Test the hypothesis that the developing mouse limb displays electrical signaling properties that regulate CaV1.2. To complete these aims, we have generated various knockin, knockout, and tissue-specific gain-of-function and loss-of-function mouse models, with which we obtained preliminary data demonstrating roles for CaV1.2 within the developing limb and within developing bone. Further, we have developed methods that build upon multiple technologies to permit live Ca2+ imaging in ex vivo limb cultures isolated from mouse embryos. These methods will provide an unprecedented characterization of parameters such as properties of spontaneous and evoked Ca2+ transients, resting membrane potential, dynamic changes in membrane potential, action potentials, and VGCC currents in developing limbs. Successful completion of these Aims will define novel roles for CaV1.2 in the development of tissues other than brain, heart, and endocrine tissue, thereby revealing mechanisms for many of the unexplained TS phenotypes. Because CaV1.2 anchors a large molecular complex, these studies will serve as a platform for future investigation of the roles of CaV1.2-associated proteins and their downstream signaling partners in development and whether their dysfunction also contributes to birth defects. The availability of clinically used agents that target CaV1.2 offers the opportunity to exploit the knowledge gained from the proposed experiments for new treatment paradigms.

尽管电压门控 Ca2+ 通道 (VGCC) 主要针对其在神经元中的作用进行了研究，心脏和激素分泌细胞，蒂莫西综合征（TS）中特别广泛的异常意味着 VGCC 在发育过程中发挥意想不到的作用是由于功能获得性突变。 CACNA1C，编码 L 型 Ca2+ 通道 CaV1.2 的成孔 α1C 亚基的基因。关于 TS 的研究主要集中在突变通道如何导致心律失常或自闭症，但几乎没有研究研究了 CaV1.2 对伴随表型（例如并指畸形）的贡献。 CaV1.2 的贡献将是富有成效的，因为这些 TS 表型包括多种常见的出生缺陷，这意味着 CaV1.2 信号传导功能失调通常是发育异常的常见原因。 CaV1.2 功能失调对出生缺陷的影响表明，CaV1.2 具有重要作用，但在此我们提出三个目标： 1：检验 Ca2+ 流入的假设。通过TS突变体CaV1.2影响指间细胞凋亡；2：检验Ca2+通过CaV1.2流入的假设；控制骨骼发育；3：检验发育中的小鼠肢体显示出电的假设调节 CaV1.2 的信号传导特性。为了完成这些目标，我们产生了各种敲入、敲除和组织特异性功能获得和功能丧失小鼠模型，我们通过这些模型获得了证明 CaV1.2 作用的初步数据此外，在肢体发育和骨骼发育过程中，我们还开发了基于此的方法。多种技术可对从小鼠胚胎中分离的离体肢体培养物进行活体 Ca2+ 成像。方法将提供前所未有的参数表征，例如自发和诱发 Ca2+ 瞬变、静息膜电位、膜电位动态变化、作用肢体发育中的电位和 VGCC 电流。这些目标的成功完成将定义 CaV1.2 在其他组织发育中的新作用比大脑、心脏和内分泌组织更重要，从而揭示了许多无法解释的 TS 的机制由于 CaV1.2 锚定了一个大的分子复合物，因此这些研究将作为一个平台。 CaV1.2 相关蛋白及其下游信号传导伙伴的作用的未来研究发育以及它们的功能障碍是否也会导致出生缺陷。针对 CaV1.2 的药物提供了利用从提议的知识中获得的知识的机会新治疗范例的实验。